Multiple somatic rearrangements are often found in cancer genomes; however, the underlying processes of rearrangement and their contribution to cancer development are poorly characterized. Here we use a paired-end sequencing strategy to identify somatic rearrangements in breast cancer genomes. There are more rearrangements in some breast cancers than previously appreciated. Rearrangements are more frequent over gene footprints and most are intrachromosomal. Multiple rearrangement architectures are present, but tandem duplications are particularly common in some cancers, perhaps reflecting a specific defect in DNA maintenance. Short overlapping sequences at most rearrangement junctions indicate that these have been mediated by non-homologous end-joining DNA repair, although varying sequence patterns indicate that multiple processes of this type are operative. Several expressed in-frame fusion genes were identified but none was recurrent. The study provides a new perspective on cancer genomes, highlighting the diversity of somatic rearrangements and their potential contribution to cancer development.
Multiple somatic rearrangements are often found in cancer genomes; however, the underlying processes of rearrangement and their contribution to cancer development are poorly characterized. Here we use a paired-end sequencing strategy to identify somatic rearrangements in breast cancer genomes. There are more rearrangements in some breast cancers than previously appreciated. Rearrangements are more frequent over gene footprints and most are intrachromosomal. Multiple rearrangement architectures are present, but tandem duplications are particularly common in some cancers, perhaps reflecting a specific defect in DNA maintenance. Short overlapping sequences at most rearrangement junctions indicate that these have been mediated by non-homologous end-joining DNA repair, although varying sequence patterns indicate that multiple processes of this type are operative. Several expressed in-frame fusion genes were identified but none was recurrent. The study provides a new perspective on cancer genomes, highlighting the diversity of somatic rearrangements and their potential contribution to cancer development.
Cytogenetic studies over several decades have shown that somatic rearrangements, in particular chromosomal translocations, occur in many human cancer genomes [1] [2] [3] . The prevalence of rearrangements is, however, variable with some cancer genomes exhibiting few and others, including the genomes of many common adult epithelial cancers, showing many.
Somatic rearrangement is a common mechanism for the conversion of normal genes into cancer genes [1] [2] [3] [4] [5] . Indeed, of the ,400 genes that are currently known to be somatically mutated and implicated in cancer development, most are altered by genomic rearrangement (http://www.sanger.ac.uk/genetics/CGP/Census/). These rearrangements usually result in the formation of a fusion gene, derived from two disrupted normal genes, from which a fusion transcript and protein is generated. In some instances, however, rearrangements place an intact gene under the control of new regulatory elements or cause internal reorganization of a gene. These events usually result in activation of the protein to contribute to oncogenesis, as in the paradigm of the BCR-ABL fusion gene in chronic myeloid leukaemia 6 .
Most of the currently known fusion genes are operative in leukaemias, lymphomas and sarcomas 1,3 , although similar cancer-causing rearrangements in RET, NTRK1, NTRK3, BRAF and TFE3 were reported in rare epithelial cancers many years ago (http://www.sanger. ac.uk/genetics/CGP/Census/). Activated fusion genes in common adult epithelial cancers, such as those of the ETS transcription factor family in prostate cancer 7 and the ALK gene in lung adenocarcinoma 8 , were discovered only recently and not through the conventional strategy of positional cloning of cytogenetically ascertained chromosomal breakpoints. Their late emergence primarily reflects the complexity of cytogenetically visible rearrangement patterns in the genomes of many adult epithelial cancers and the consequent difficulty in prior selection of driver rearrangements for further study among the many likely passenger changes 9 . Rearrangements also constitute a subset of mutational events that result in inactivation of recessive cancer genes (tumour suppressor genes) and underlie genomic amplifications that result in increased copy number of cancer genes 10-12 . In recent years, the diversity of prevalence and pattern of point mutations and copy number changes in cancer genomes have been elucidated by systematic polymerase chain reaction (PCR)-based resequencing studies and by application of high-resolution copy number arrays, respectively [13] [14] [15] [16] . Understanding of the basic patterns of rearrangement in most cancers, however, remains rudimentary. We recently demonstrated that second-generation sequencing of both ends of large numbers of DNA fragments generated from cancer genomes allows comprehensive characterization of rearrangements 17 . Here we apply this approach to a series of breast cancers to explore patterns of rearrangement and their potential contribution to cancer development.
Landscapes of rearrangement
Twenty-four breast cancers were investigated by sequencing both ends of ,65,000,000 randomly generated ,500-bp DNA fragments from each cancer on Illumina GAII Genome Analysers (Supplementary Fig. 1 ). The series included primary tumours and immortal cancer cell lines, examples of the commonest phenotypically defined subtypes and cases with high-risk germline predisposition mutations in BRCA1, BRCA2 and TP53 (Table 1) . Rearrangements were initially identified as discordant paired-end reads that did not map back to the reference human genome in the correct orientation with respect to each other and/or within ,500 bp of each other. These were subsequently confirmed and evaluated for somatic or germline origin.
A total of 2,166 confirmed somatic rearrangements were identified among the 24 cancers (Supplementary Tables 1 and 2 ). The presence of multiple read pairs spanning each rearrangement ( Supplementary  Table 1 ), easily detectable copy number changes associated with many and targeted fluorescence in situ hybridization (FISH) studies on a subset indicate that most rearrangements are in cells of the dominant cancer clone and not in minority cell populations. By investigating whether rearrangements were found for 200 changes in genomic copy number, we estimate that ,50% of rearrangements have been detected.
Some cancers carried many rearrangements. For example, the breast cancer cell line HCC38 has at least 238 ( Fig. 1 ), many more than could have been predicted from cytogenetic studies (http://www.path.cam. ac.uk/,pawefish/BreastCellLineDescriptions/HCC38.html). However, there is substantial variation in prevalence, with some primary breast cancers carrying only a single rearrangement ( Fig. 1 , Supplementary  Tables 1 and 2 , and Supplementary Fig. 2 ). Overall, breast cancer cell lines showed more rearrangements (median 101, range 58-245) than primary cancers (median 38, range 1-231). This difference may be due to the acquisition of additional rearrangements during in vitro culture. However, it may also reflect less sensitive detection of rearrangements in primary cancers due to contaminating normal tissue or the relative propensity of some subclasses of breast cancer, for example metastases generating pleural effusions, to become established in culture. In some cancers rearrangements are evenly distributed through the genome. By contrast, in others they cluster in and connect genomic regions showing amplification. The rearrangement architecture in such amplicons is often highly complex 10, 11 .
Architectures of rearrangement
The orientations and relative chromosomal locations of the two genomic segments forming each rearrangement can be used as the basis of a rearrangement classification system. This may be further elaborated using information from copy number and other analyses that allow reconstruction of the genomic architecture associated with each rearrangement. For the purposes of this report, we have derived a simplified version of this system, classifying each rearrangement according to (1) whether it is in an amplicon or not; (2) if not in an amplicon whether it is interchromosomal or intrachromosomal; and (3) if intrachromosomal whether it results in a deletion, tandem duplication, or rearrangement of inverted orientation ( Fig. 1b ).
There were 1,311 intrachromosomal and 239 interchromosomal rearrangements (excluding rearrangements within amplicons of which 397 were intrachromosomal compared with 219 interchromosomal) ( Table 2 and Supplementary Tables 1 and 2 ). Thus, intrachromosomal rearrangements substantially outnumber interchromosomal rearrangements in breast cancer genomes. The breakpoints of 1,574 out of 1,708 intrachromosomal rearrangements were within 2 Mb of each other. These patterns are presumably attributable to the greater likelihood of physical interaction between two positions on the same chromosome compared to positions on different chromosomes-perhaps due to individual chromosomes occupying domains in the nucleusand between two locations that are in close proximity on the same chromosome. The predominance of intrachromosomal rearrangements has not previously been appreciated because of the limited resolution of cytogenetic studies and because FISH-based approaches, such as spectral karyotyping, generally use a single fluorescence colour per chromosome.
The most commonly observed architecture of rearrangement was tandem duplication (there were 739 tandem duplications, 357 deletions and 215 rearrangements with inverted orientation; Table 2 and Supplementary Tables 1 and 2 ). The evidence that these are truly tandem insertions derives from the structure of the genomic rearrangement itself supported by complementary DNA and FISH studies (Tables 3 and 4 and Supplementary Figs 3 and 4 ). The duplicated segments ranged in size from 3 kb to greater than 1 Mb (Supplementary Table 1 ). Despite being the commonest class of rearrangement in breast cancer, tandem duplications have previously been overlooked because they are intrachromosomal and involve small chromosomal segments beyond the resolution of cytogenetics or previous generations of copy number arrays.
There were major differences between individual breast cancers in the number of tandem duplications ( Fig. 1b and Supplementary Fig. 5 ). Some exhibited more than one-hundred whereas others showed few or none. The mechanistic basis for these differences is unknown, but may be due to a defective DNA maintenance process which confers a 'mutator phenotype'. This would be similar, in principle, to the defects in DNA mismatch repair that are responsible for microsatellite instability in some cancers. This putative mutator phenotype is unlikely to be directly related to deficiencies in BRCA1-or BRCA2-mediated DNA repair, as some cancers arising in individuals with germline mutations in these genes have few tandem duplications. Large numbers of tandem duplications were generally observed, however, in cancers that do not express oestrogen and progesterone receptors.
Sequences at rearrangement junctions DNA sequence across the rearrangement junction was obtained from 1,821 (3,642 breakpoints) of the 2,166 confirmed rearrangements (Supplementary Table 3 ). The sequences 100 bp either side of each breakpoint were examined for the presence of motifs and sequence content. No striking signatures were observed, although there was a slight deficit of CNG base pairs compared to the genome as a whole (P , 0.001) and modest enrichment of some motifs (Supplementary Tables 4 and 5 ). However, no single motif was commonly found in any class of rearrangement. The sequences either side of each rearrangement junction were then compared to each other. In most instances the two contributing DNA segments showed a short stretch of identical sequence, known as an overlapping microhomology, immediately adjacent to the rearrangement junction which was present only once in the rearranged DNA (Fig. 1c , Table 2 , Supplementary Table 3 and Supplementary Fig. 6 ). Approximately 15% of rearrangements showed non-templated sequence at the rearrangement junction ( Table 2 , Supplementary Table 3 and Supplementary Fig. 7 ). In many, this is only a few base pairs long, although the longest segment of this type was 154 bp. A further 3.8% of rearrangements included one or more small fragments of DNA (,500bp) from elsewhere in the genome interposed between the rearrangement breakpoints identified by the paired end sequencing. We have previously termed these small DNA fragments 'genomic shards' 10, 17 .
Overlapping microhomologies and non-templated sequences at rearrangement junctions are often considered to be signatures of a non-homologous end-joining (NHEJ) DNA double-strand break repair process [18] [19] [20] [21] . The segments of overlapping microhomology In the top section of Table 2 , the mean per case and range are indicated in parentheses. 
Gene accession numbers and exons fused are outlined in Supplementary Table 6 . * Gene fusion is amplified. { Predicted to be an out-of-frame gene fusion. However, RT-PCR across the exon-exon fusion boundary demonstrated both an out-of-frame and an in-frame gene fusion due to alternative splicing. NATURE | Vol 462 | 24/31 December 2009 are believed to mediate alignment of the two DNA fragments that are joined. It has, however, recently been proposed that complex germline rearrangements with genomic shards and overlapping microhomology might be due to replicative mechanisms 21 . The small proportion of complex rearrangements with genomic shards may indicate that this mechanism is relatively infrequently operative in breast cancer. It has previously been suggested that there exist multiple NHEJ repair processes that may be characterized by different lengths of overlapping microhomology at rearrangement junctions 21, 22 . To investigate this possibility we examined the distribution of microhomology lengths in each breast cancer ( Fig. 1c and Supplementary Fig. 6 ). In some breast cancers, rearrangements with zero base pairs of microhomology were most frequent, whereas in others rearrangements with two or more base pairs were the commonest class. Rearrangements with zero base pairs of microhomology were most common in amplicons, in contrast to all other classes of rearrangement in which the modal class of microhomology was 2 bp (Fig. 2) . These differences are unlikely to be due to chance (P , 0.001) and indicate that there are at least two classes of NHEJ repair which are operative to different extents in different breast cancers 21 .
Because the analysis of paired-end sequences requires alignment to the reference human genome and because sequences within repetitive elements are more likely to misalign it is conceivable that we have missed classes of rearrangement mediated by repeats. To investigate this possibility further we constructed libraries from the breast cancer cell line HCC1187 in which the sequenced ends were 3 kb rather than 500 bp apart. The 3-kb paired ends will flank the majority of common repeats and thus allow detection of rearrangements mediated by them. Although additional rearrangements were detected, a distinct class of repeat-mediated rearrangement was not found (data not shown).
Rearrangements of protein coding genes
Fifty per cent of rearrangements fell within the footprint of a protein coding gene compared to 40% expected by chance (P , 10 27 ). The reasons for this striking enrichment of rearrangements in genic regions are not clear. Because rearrangements that confer selective advantage on a cancer clone are a priori more likely to be located in genes it is conceivable that some of this effect is due to selection and that a subset of rearrangements is implicated in cancer development. However, it may be more plausible that there are structural properties of genic regions that increase the likelihood of a DNA double-strand break occurring, perhaps dependent on active transcription or chromatin configuration.
Twenty-nine rearrangements were predicted to generate in-frame gene fusions. Using exon-exon PCR with reverse transcription (RT-PCR), rearranged transcripts from 19 out of 22 in-frame fusion genes in non-amplified regions and from 2 out of 6 (1 not determined) in amplified regions were found (Table 3) . Thus, most in-frame rearranged genes from non-amplified regions have the requisite 59 and 39 DNA sequences for transcript formation and stability. Conversely, most from amplified regions do not and these rearrangements probably represent fragments of one or both genes reflecting the high density of rearrangements often present in these regions 10 . Sixty-six in-frame internally rearranged genes were also identified. Rearranged transcripts were present in 39 out of 58 assessed (Table 4 ). In some cancers multiple in-frame rearranged and expressed genes are present (Tables 3 and 4 and Supplementary Tables 6 and 7) . Several in-frame fusion genes are potentially of biological interest as candidates for new cancer genes. Notably, two were members of the ETS family of transcription factors. ETV6 is rearranged to form cancer genes with multiple different fusion partners in leukaemias 23 , congenital fibrosarcoma 24 and myelodysplastic syndrome. It also forms a rearranged cancer gene with NTRK3 in the rare subclass of secretory breast cancer 25 . Here, ETV6 was fused to ITPR2 ( Fig. 3) through an inversion involving intron 2, a site previously reported in other cancers 23 , and was rearranged in a further breast cancer without clearly forming an in-frame fusion gene. ITPR2 encodes inositol-1,4,5-triphosphate receptor type 2 which is involved in signal transduction and regulation of cellular calcium fluxes. The second rearrangement fused EHF, which has not been previously implicated in cancer development, to NFIA, a transcription factor involved in adenovirus replication ( Supplementary Fig. 3 ).
Fusion genes implicated in cancer development are likely to be recurrent. However, none of the novel fusion genes we identified was present in more than one out of the 24 cancers screened. Three expressed, in-frame fusion genes were examined by FISH (ETV6-ITPR2, NFIA-EHF and SLC26A6-PRKAR2A) and twenty by RT-PCR across the rearranged exon-exon junction in 288 additional breast cancer cases. No further examples were found, indicating that they are either passenger events or that they contribute infrequently to breast cancer development.
Rearrangements were found in several known cancer genes including BRAF, PAX3, PAX5, NSD1, PBX1, MSI2 and ETV6 (see above). Each of these is a partner in a fusion gene in other classes of human cancer and was rearranged in two of the 24 samples analysed, although in many cases an in-frame fusion gene was not obviously generated ( Supplementary Table 8 ). Rearrangements found in RB, APC, FBXW7 and other recessive cancer genes may have resulted in gene inactivation to contribute to cancer development.
Several other genes were rearranged in multiple cancers (Supplementary Table 9 ). Some are in amplified regions surrounding HCC1187  F8, FBXL20, GMDS, MED13L, RB1  HCC1395  CADPS2, DYNC2H1, KIAA0802, MBTPS1, TLE1  HCC1937  LRBA, RUNX1, SEMA3D, SSBP3  HCC38  EPHA3, EPS15, FRY, KCNMB2, REPS1, SLC4A4, GIGYF2  PD3664a  C12orf35, FAM164A, GABRP, HOMER2, INADL, KCNMA1, NFE2L3,  ODZ1 
Gene accession numbers and exons fused are outlined in Supplementary Table 7 . ERBB2 (for example ACCN1, which is rearranged in four out of the 24 breast cancers) or other known targets of genomic amplification in breast cancer. It is likely that these are recurrently rearranged because of the high density of rearrangements associated with these regions of recurrent genomic amplification. Others, however, are not in regions of genomic amplification. For example, SHANK2 was rearranged in five of the 24 breast cancers, whereas IGF1R, GRHL2, EFNA5 and MACROD2 were each rearranged in four. These recurrently rearranged genes generally have large genomic footprints and may simply represent bigger targets for randomly positioned rearrangements (Supplementary Table 9 ). For some, however, an elevated local rate of DNA double strand breakage ('fragility') may also contribute to the clustering of rearrangements.
Discussion
This study has generated the most comprehensive insight thus far into patterns of somatic rearrangement in cancer genomes. Most rearrangements in breast cancer are intrachromosomal. Tandem duplications seem to be the most common subclass and are known to form activated cancer genes in other cancer types 26, 27 . The high prevalence of tandem duplications in a subset of cancers suggests the presence of a defect in DNA maintenance which generates this particular class of rearrangement. The underlying abnormality responsible for this phenotype is unknown. It may reside in the licensing mechanisms responsible for defining, priming and monitoring origins of DNA replication 28 . Breast cancers are highly heterogeneous and are subclassified on the basis of oestrogen receptor, progesterone receptor and ERBB2 expression and by messenger RNA expression profiles 29, 30 . Subclasses defined in these ways show correlations with patterns of genomic alteration 31, 32 . Breast cancers with many tandem duplications are usually oestrogen-and progesterone-receptor negative and classified by expression profile as basal-like. In contrast, cancers with few rearrangements or with rearrangements within amplicons (other than those involving ERBB2) are usually oestrogen-receptor positive and classified as luminal A and luminal B types, respectively.
Many novel in-frame fusion genes or internally rearranged genes were identified, most of which were expressed. None, however, were found to be recurrent. Approximately 2% of rearrangements would be expected to generate an in-frame fusion gene by chance, compared to 1.6% observed. It is therefore likely that most are passenger events. Nevertheless, as previously suggested for somatic point mutations 13, 14 it may be that multiple, infrequently rearranged cancer genes are operative in breast cancer as they are in leukaemia 2 . Furthermore, detailed analysis of rearrangement breakpoints will be necessary to investigate the possibility of fusions between promoters/regulatory elements and intact genes that result in deregulation of expression. Much larger series will be required to investigate comprehensively the possibility of recurrent cancer-causing rearrangements in breast cancer.
Exhaustive sequencing of substantial numbers of cancer genomes to yield complete catalogues of all classes of somatic mutations will gather pace over the next few years. The current study offers insight into the complexity of rearrangement patterns that will be encountered in solid tumour genomes, demonstrates the potential for generation of active rearranged genes that may be implicated in cancer development, and illustrates the types of information that will emerge on mutational processes that have been operative during the development of individual cancers.
METHODS SUMMARY
Paired-end sequence reads of 37 bp were generated on the Illumina Genome Analyser from ,500-bp insert genomic libraries and aligned to the human reference genome (NCBI Build 36) using MAQ 33 . Correctly mapping reads were used to generate genome-wide copy number information and discordantly mapping reads defined potential rearrangements 17 . Putative rearrangements were PCR amplified in tumour and matching normal DNA and proven somatic rearrangements were capillary sequenced to resolve breakpoints to base-pair level. Structural variants predicted to generate novel gene fusions or to internally rearrange genes were further characterized by RT-PCR and sequencing from tumour-derived total RNA. 
